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Objectives:	   Infectious	   agents	   triggering	   haemophagocytic	   lymphohistiocytosis	   (HLH)	   primarily	   involve	  
the	  herpes	  virus	  group.	  We	  report	  a	  case	  of	  HLH	  precipitated	  by	  Plasmodium	  falciparum.	   	  
	  
Materials	   and	   methods:	   Clinical	   and	   laboratory	   findings	   in	   a	   patient	   presenting	   with	   fever	   were	  
collected.	  After	  confirmation	  of	  acute	  malaria,	  anti-­‐malarial	  treatment	  was	  administered.	  
	  
Results:	   Despite	   initial	   favourable	   evolution,	   the	   patient	   developed	   fever	   again	   together	   with	   a	  
worsening	   of	   the	   haematological	   parameters	   and	   increased	   ferritin	   levels.	   A	   bone	   marrow	   biopsy	  
confirmed	  the	  diagnosis	  of	  HLH.	  
	  
Conclusion:	   This	   case	   illustrates	   that	   HLH	   should	   be	   considered	   in	   the	   differential	   diagnosis	   of	   acute	  
malaria	  in	  patients	  with	  persisting	  fever	  and	  pancytopenia.	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Introduction	  
	  
Haemophagocytic	   lymphohistiocytosis	   (HLH)	   is	   a	   clinical	   entity	   characterized	   by	   fever,	   pancytopenia	  
and	   haemophagocytosis	   in	   bone	   marrow	   and	   possibly	   other	   tissues1.	   It	   can	   occur	   as	   a	   primary	  
syndrome,	   referred	   to	   as	   familial	   HLH,	   or	   as	   a	   syndrome	   secondary	   to	   an	   underlying	   autoimmune,	  
neoplastic	  or	   infectious	  disease,	  referred	  to	  as	  reactive	  HLH.	   Infectious	  agents	  triggering	  reactive	  HLH	  
primarily	   involve	   the	   herpes	   virus	   group,	   predominantly	   Epstein-­‐Barr	   virus	   (EBV).	   Here	   we	   report	   a	  
patient	  presenting	  with	  reactive	  HLH	  precipitated	  by	  Plasmodium	  falciparum	  infection.	   	  
	  
Case	  report	   	  
	  
A	  19-­‐year-­‐old	  Belgian	  male	  was	  admitted	  to	  hospital	  because	  of	  a	  fever	  (up	  to	  40°C),	  which	  he	  had	  had	  
for	  2	  days.	  He	  complained	  of	  headache,	  diffuse	  muscular	  pain	  and	  nausea.	  Four	  days	  before	  the	  onset	  
of	  fever,	  he	  had	  returned	  from	  the	  Democratic	  Republic	  of	  Congo,	  where	  he	  had	  stayed	  for	  3	  weeks.	  He	  
had	  not	  taken	  malaria	  prophylaxis.	  
There	   was	   nothing	   of	   significance	   in	   his	   medical	   history.	   Physical	   examination	   showed	   a	   man	   who	  
appeared	  ill,	  with	  a	  tympanic	  temperature	  of	  39°C.	  His	  blood	  pressure	  was	  135/74	  mmHg	  and	  rate	  was	  
114	   beats/min.	   The	   cervical	   lymph	   nodes	   were	   slightly	   swollen.	   The	   rest	   of	   the	   physical	   exam	   was	  
normal.	   	  
Laboratory	   tests	   showed	   elevated	   levels	   of	   C-­‐reactive	   protein	   and	   cytolytic	   liver	   enzymes	   as	  well	   as	  
thrombocytopenia	  (Table	  1).	  Chest	  X-­‐ray	  was	  normal.	  
The	  clinical	  suspicion	  of	  acute	  malaria	  was	  confirmed	  by	  a	  thick	  blood	  smear,	  showing	  the	  presence	  of	  P.	  
falciparum	  with	  only	   rare	  erythrocytes	  parasitized.	  A	   supportive	   treatment	  and	  oral	  quinine	  sulphate	  
(500	   mg	   tid),	   to	   be	   followed	   by	   doxycyclin	   from	   day	   3	   onwards,	   was	   initiated.	   Because	   of	  
gastrointestinal	   intolerance,	   this	   schedule	  was	   changed	   to	   atovaquone	   250	  mg/proguanil	   100	  mg,	   4	  
tablets	  daily	   for	  3	  consecutive	  days,	  starting	  on	  day	  3.	  Abdominal	  ultrasound,	  performed	  on	  day	  2	  of	  
admission,	  showed	  slight	  splenomegaly	  (12.7	  cm).	  
Although	  the	  clinical	  evolution	  was	  initially	  favourable,	  from	  day	  3	  onwards,	  the	  patient	  started	  having	  
a	  high	  fever	  again,	  up	  to	  39°C.	  He	  complained	  of	  headache	  and	  there	  was	  intermittent	  confusion	  with	  
signs	   of	   meningismus.	   Gradual	   worsening	   of	   the	   haematological	   parameters	   was	   observed	   with	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   Day	  
	   0	   1	   2	   3	   4	   5	   6	   8	  
Maximum	  body	  temperature	  (°C)	   39.0	   40.0	   38.2	   39.0	   37.5	   37.5	   36.4	   36.5	  
	   Normal	  Values	   	   	   	   	   	   	   	   	  
Haemoglobin	  (g/dl)	   13.0–16.5	   15.2	   14.0	   12.8	   12.3	   11.9	   11.4	   10.8	   10.8	  
Platelets	  (x10³/mm³)	   158–450	   79	   52	   30	   27	   43	   50	   84	   194	  
White	   blood	   cells	  
(x10³/mm³)	  
3.6–9.6	   3.5	   3.7	   1.5	   1.8	   3.8	   3.9	   4.5	   6.7	  
Neutrophils	  (x10³/mm³)	   1.4–6.7	   2.9	   3.1	   0.8	   0.7	   1.1	   1.3	   1.7	   2.6	  
Atypical	  lymphocytes	  (%)	   0.0	   0.0	   0.0	   14.5	   21.0	   12.0	   7.5	   5.0	   4.0	  
Creatine	  kinase	  (U/l)	   <145	   288	   nd	   6604	   5602	   2250	   813	   466	   205	  
LDH	  (U/l)	   241–549	   934	   nd	   3719	   1934	   1196	   862	   859	   809	  
ALT	  (U/l)	   21–72	   111	   nd	   792	   500	   409	   244	   150	   65	  
AST	  (U/l)	   16–48	   100	   nd	   592	   430	   366	   288	   235	   146	  
γ-­‐GT	  (U/l)	   14–47	   nd	   nd	   64	   76	   83	   88	   98	   nd	  
AF	  (U/l)	   65–220	   nd	   nd	   110	   nd	   148	   176	   233	   158	  
Total	  bilirubin	  (mg/dl)	   0.2–1.0	   nd	   nd	   4.94	   4.83	   3.93	   2.67	   2.10	   1.59	  
Direct	  bilirubin	  (mg/dl)	   <0.5	   nd	   nd	   3	   3.2	   2.3	   1.6	   1.1	   0.6	  
Fibrinogen	  (mg/dl)	   180–400	   nd	   nd	   375	   40	   	   	   291	   	  
CRP	  (mg/l)	   <5	   94.1	   131.0	   236.0	   172.0	   89.4	   52.7	   33.8	   14.7	  
PT	  (%)	   >70	   62	   nd	   68	   76	   87	   94	   91	   nd	  
Ferritin	  (µg/l)	   30–400	   nd	   nd	   nd	   nd	   4102	   nd	   nd	   nd	  
Fasting	  triglycerides	  (mg/dl)	   <150	   nd	   nd	   467	   727	   nd	   nd	   nd	   nd	  
LDH,	   lactate	   dehydrogenase;	   AST,	   aspartate	   aminotransferase;	   ALT,	   alanine	   aminotransferase;	   γ-­‐GT,	  
gamma-­‐glutamyltransferase;	  AF,	  Alkaline	  posphatase	  or	  ALP;	  CRP,	  C-­‐reactive	  protein;	  PT,	  prothrombin	  time;	  nd,	  not	  done	  
	  
Table	  1:	  Evolution	  of	  tympanic	  temperature	  and	  laboratory	  parameters	  
	  
New	   blood	   cultures	   remained	   negative.	   A	   thick	   blood	   smear	   showed	   persistently	   low	   falciparum	  
parasitaemia.	  Serologic	  studies	  were	  compatible	  with	  passed	  infection	  with	  EBV	  and	  cytomegalovirus.	   	   	  
This	   clinical	   picture	   caused	   the	   suspicion	   of	   HLH.	   Triglycerides	   and	   ferritin	   levels	   turned	   out	   to	   be	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megakaryocytic	  hyperplasia	  and	  a	  markedly	  increased	  number	  of	  benign-­‐appearing	  histiocytes	  without	  




Figure	  1:	  Bone	  marrow	  biopsy	  
	  
Bone	   marrow	   aspirate	   smears	   (May-­‐Grünwald-­‐Giemsa	   staining)	   demonstrate	   marked	  
haemophagocytosis.	   Benign-­‐appearing	   histiocytes	   contain	   small,	   round	   nuclei	   (nu)	   with	   condensed	  
chromatin.	   The	   cytoplasm	   is	   abundant	   with	   ingestion	   of	   mature	   and	   immature	   haematopoietic	  
elements,	  mainly	  erythroblasts.	  
According	   to	   the	   initial	   clinical	  evolution	  and	   the	   findings	  on	  blood	  smear,	  no	  other	  active	   treatment	  
was	  considered.	  Broad-­‐spectrum	  antibiotics	  (a	  combination	  of	  cefepime	  and	  amikacine	  intravenously)	  
were	  given	  as	  empirical	  coverage	  during	  febrile	  neutropenia.	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The	   term	   haemophagocytosis,	   first	   reported	   in	   1939,	   describes	   the	   pathologic	   finding	   of	   activated	  
monocytes,	   macrophages	   and	   histiocytes	   engulfing	   erythrocytes,	   leukocytes	   and	   platelets	   in	   bone	  
marrow	  and	  other	  tissues1,2.	   	  
Familial	  HLH	  is	   inherited	  in	  an	  autosomal	  recessive	  manner	  with	  symptoms	  usually	  evident	  within	  the	  
first	   years	   of	   life3.	   The	   association	   between	   HLH	   and	   infectious	   diseases	   can	   be	   challenging	   for	   the	  
clinician	  because	  both	   reactive	   and	   familial	  HLH	  are	  often	  precipitated	  by	   infections.	  Moreover,	  HLH	  
may	  mimic	  infectious	  illnesses,	  such	  as	  overwhelming	  bacterial	  sepsis,	  or	  it	  may	  obscure	  the	  diagnosis	  
of	  a	  precipitating,	  treatable	  infectious	  illness.	  Our	  patient	  developed	  signs	  of	  HLH	  within	  2–3	  days	  after	  
the	  diagnosis	  of	  acute	  malaria.	  No	  other	  possible	  triggering	  infection	  could	  be	  demonstrated.	  HLH	  was	  
suspected	   on	   clinical	   grounds,	   with	   a	   differential	   diagnosis	   of	   acute	   malaria	   evolving	   into	   “severe	  
malaria”	  or	  malaria	  complicated	  by	  bacterial	  septicaemia.	   	  
Although	  the	  underlying	  pathophysiologic	  mechanisms	  remain	  unclear,	   it	   is	   thought	   that	  all	  HLHs	  are	  
due	  to	  some	  form	  of	  functional	  impairment	  of	  cytotoxic	  T	  lymphocytes	  and	  natural	  killer	  cells,	  resulting	  
in	   the	   inability	   to	   clear	   the	   antigenic	   stimulus	   and	   to	   turn	   off	   the	   inflammatory	   response,	   ultimately	  
leading	   to	   hypercytokinaemia	   characteristic	   of	   HLH4.	   However,	   the	   exact	   mechanisms	   by	   which	  
abnormal	   cytokine	   elaboration	   results	   in	   HLH	   are	   still	   elusive.	   Once	   the	   cytokine	   cascade	   has	   been	  
triggered,	  HPS	  may	  continue	  to	  proceed	  independently	  of	  the	  presence	  of	  an	  initial	  trigger.	  
The	   diagnostic	   criteria	   for	   HLH	   include	   clinical,	   laboratory	   and	   histopathologic	   features5.	   Fever	   and	  
splenomegaly	  are	  the	  most	  common	  clinical	  signs	  but	  hepatomegaly,	   lymphadenopathy,	   jaundice	  and	  
rash	   have	   also	   been	   described.	   Encephalopathy,	  meningismus	   and	   seizures	   are	   the	  most	   commonly	  
reported	   central	   nervous	   manifestations.	   The	   most	   prominent	   laboratory	   abnormality	   noted	   is	  
cytopenia.	  Blood	  chemistry	  may	  suggest	  haemolysis	  and	  most	  patients	  have	  hypertriglyceridaemia	  as	  
well	   as	   marked	   elevation	   of	   serum	   ferritin.	   Serum	   fibrinogen	   is	   typically	   low.	   Histopathologically,	  
haemophagocytosis	   can	   be	   demonstrated	   in	   bone	   marrow,	   spleen,	   liver	   and	   lymph	   nodes	   and	  
occasionally	  in	  the	  central	  nervous	  system	  and	  the	  skin.	  In	  our	  patient,	  HLH	  was	  suspected	  because	  of	  
cytopenia	  affecting	  two	  lineages	  as	  well	  as	  prominently	  elevated	  serum	  ferritin	  and	  triglyceride	  levels.	  
A	  bone	  marrow	  smear	  allowed	  confirmation	  of	  the	  diagnosis.	   	  
For	   patients	   with	   reactive	   HLH	   associated	   with	   pathogens	   other	   than	   EBV,	   supportive	   care	   and	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patient5.	   EBV-­‐associated	   HLH	   is	   almost	   universally	   fatal	   if	   untreated.	   Therefore,	   patients	   should	   be	  
treated	  with	  combination	  chemotherapy	  and	  immunotherapy	  (HLH-­‐94	  treatment	  protocol),	  regardless	  
of	   whether	   they	   are	   thought	   to	   have	   familial	   HLH.	   However,	   the	   distinction	   between	   reactive	   and	  
familial	   HLH	   triggered	   by	   a	   viral	   infection	   is	   important	   as	   allogeneic	   haematopoietic	   stem	   cell	  
transplantation	  is	  the	  only	  curative	  therapy	  in	  patients	  with	  familial	  HLH	  who	  attain	  remission.	   	  
This	   case	   illustrates	   that	   HLH	   should	   be	   considered	   in	   the	   differential	   diagnosis	   of	   acute	   malaria	  
patients	  with	  persisting	  fever	  and	  pancytopenia.	  Early	  recognition	  of	  this	  rare	  complication	  enables	  the	  
clinician	   to	   consider	   timely	   immunosuppressive	   treatment	   in	   case	   there	   is	   no	   spontaneous	   recovery	  
and	  successful	  treatment	  of	  the	  underlying	  malaria	  attack	  alone.	  
	  
Learning	  Points	  
• HLH	  may	  mimic	  infectious	  illnesses.	   	  
• HLH	   should	   be	   considered	   in	   the	   differential	   diagnosis	   of	   acute	   malaria	   in	   patients	   with	  
persisting	  fever	  and	  pancytopenia.	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